RNA interference experiments targeting CHST11 were conducted in DLBCL cells, with shCHST11#3 presenting higher efficiency at mRNA and protein levels (Fig. 5G, H). The gene discussed is CHST11; the disease is diffuse large B-cell lymphoma.